Showing results (1181-1190 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|April 23, 2026
Identifying High-Risk Smoldering Multiple Myeloma for Early InterventionCecilie V Maeng, Sæmundur Rögnvaldsson, Christian Brieghel, et al.
JAMA Oncology|May 21, 2026
Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as PrecancerousAndrew J Vickers, Matthew Cooperberg, Christian P Pavlovich, et al.
JAMA Oncology|June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus RecommendationsNikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
JAMA Oncology|May 17, 2019
Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: An Analysis of Randomized Clinical TrialsRonak Saluja, Louis Everest, Sierra Cheng, et al.
JAMA Oncology|May 28, 2026
Circulating Tumor DNA in Early Breast Cancer: A ReviewIlana Schlam, Sara M Tolaney, Nancy U Lin, et al.
JAMA Oncology|March 10, 2017
Patients' and Parents' Needs, Attitudes, and Perceptions About Early Palliative Care Integration in Pediatric OncologyDeena R Levine, Belinda N Mandrell, April Sykes, et al.
JAMA Oncology|July 2, 2026
Cardiac Risk After Heart-Sparing Breast RadiotherapySarah Quirk, Katelyn M Atkins, Natalie Logie, et al.
JAMA Oncology|July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
JAMA Oncology|June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP InhibitorsLucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
JAMA Oncology|July 30, 2026
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical TrialNing Lyu, Jun-Zhe Yi, Xin-Tong Wu, et al.
Pageof 162